SCHEMBL7108663

SCHEMBL7108663

OCC(O)C(O)CNCc1cncc(CNCC(O)C(O)CO)n1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PNP P00491 4/20 0.39
▸ KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7108772 0.84 PNP (0.38) PNPKDM4E
SCHEMBL7650049 0.82 TRPV3 (0.43) PNPKDM4E
SCHEMBL7106463 0.81 PNP (0.36) PNP
SCHEMBL7105047 0.81 PNP (0.43) PNPKDM4E
SCHEMBL7655578 0.79 PNP (0.39) PNP
SCHEMBL7108751 0.75 PNP (0.39) PNP
SCHEMBL7107159 0.75 LMNA (0.31) —
SCHEMBL7109077 0.75 LMNA (0.31) —
SCHEMBL7109071 0.75 LMNA (0.31) —
SCHEMBL7654878 0.73 CXCR4 (0.41) PNPKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001944-B1 PYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM AVENTIS PHARMA SA (FR) 2003-10-01 — — EP claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 — — US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 — — US disclosed
Send feedback